2022 Best In KLAS Acute Care EMR - Global Latin America

With the pandemic mostly past, healthcare organizations across the world are readdressing key technology priorities. EMR initiatives continue to be prioritized at most organizations. In 2022, KLAS validated 164 EMR purchase decisions impacting 532 hospitals and over 82,000 beds. 30 different vendors in 31 different countries were selected. While 2022 had the lowest validated EMR purchase activity of the last five years, certain markets remained highly active—specifically, Europe and Latin America and, to a lesser extent, Asia and the Middle East. Canada and Oceania, while relatively quiet in 2022, are poised for significant activity in 2023 due to major contracts on the horizon.

As electronic medical record (EMR) adoption grows worldwide, healthcare organizations considering this digital transformation all have the same question: what benefits can we really expect to receive from implementing an EMR? KLAS interviewed leaders at 36 non-US healthcare organizations—12 of which are HIMSS Level 6 or 7—to learn about their journey to realizing benefits from an EMR implementation. This white paper summarizes their insights, including what clinical and operational benefits they have seen, when those benefits were realized, and what recommendations they have for peer organizations.

As healthcare organizations have come out of the peak of the COVID-19 pandemic, EMR purchase decisions in Asia have ramped up. In Oceania, most public hospitals have an EMR in place, but purchase energy remains high since many public and private provider organizations are planning large-scale purchases of go-forward EMRs. This report—KLAS’ first focused exclusively on Asia and Oceania—highlights (1) market share and vendor energy in recent EMR purchase decisions and (2) vendor performance in each region based on client feedback and experience. The chart below offers a high-level view of vendors’ overall performance.

Performance

Middle East & Africa EMR 2021

09 September 21 | Everton Santos and Sidney Tate

Many healthcare organizations in the Middle East and some in Africa have made EMR purchase decisions over the last five years (2016–2020). In that time, KLAS has validated 86 EMR decisions—72 in the Middle East and 14 in Africa—impacting over 320 hospitals, with decisions made in 2018–2020 impacting (on average) at least twice as many facilities as decisions made in 2016–2017. This report will examine the customer satisfaction, market share, and recent wins and market energy of EMR vendors in the Middle East and Africa. Compared to KLAS’ previous report on EMRs in the Middle East (published in 2019), this study includes performance data on a significantly higher number of vendors, providing more expansive insights, particularly into the Middle East market.

Company/solution	Overall performance score (100-point scale)	Total evaluations	Trend (2021-2022)	Culture	Loyalty	Operations	Product	Relationship	Value

Philips Tasy Java/HTML5 (Non-US)	75.9	n=18	-1%	D+	B-	C+	B	C	C

NTT DATA ehCOS Clinic (Non-US)	73.5	n=9	+8%	D+	C	C	B	C+	C-

Oracle Health Cerner i.s.h.med (Non-US)	73	n=10	-4%	D	B-	C	C+	C+	D

MV SOUL (Non-US) (Mostly Brazil)	73	n=22	-9%	D-	B	B-	B-	D+	D

Pixeon SmartHealth (Non-US) (Brazil Only)	71.3	n=12	-4%	D-	B-	C	C	B-	D-

Dedalus MedView (Non-US) (Brazil Only)	69.4	n=10	0%	C-	C-	B-	D+	B-	F
	50.0	100.0

Company/solution	Trend (2021-2022)	Culture	Loyalty	Operations	Product	Relationship	Value

Philips Tasy Java/HTML5 (Non-US) 75.9 n=18 COMMENTS	-1%	D+	B-	C+	B	C	C
NTT DATA ehCOS Clinic (Non-US) 73.5 n=9 COMMENTS	+8%	D+	C	C	B	C+	C-
Oracle Health Cerner i.s.h.med (Non-US) 73 n=10 COMMENTS	-4%	D	B-	C	C+	C+	D
MV SOUL (Non-US) (Mostly Brazil) 73 n=22 COMMENTS	-9%	D-	B	B-	B-	D+	D
Pixeon SmartHealth (Non-US) (Brazil Only) 71.3 n=12 COMMENTS	-4%	D-	B-	C	C	B-	D-
Dedalus MedView (Non-US) (Brazil Only) 69.4 n=10 COMMENTS	0%	C-	C-	B-	D+	B-	F

Company/solution	Overall performance score (100-point scale)	Total evaluations	Culture	Loyalty	Operations	Product	Relationship	Value

Dedalus xHIS (Non-US) (DXC Technology) * L	59.4	n=5	D+	D-	D-	F	D+	F

InterSystems TrakCare EPR (Non-US) [R] (Chile Only)	84.7	n=11	B	A	B-	B	B	B

SPDATA PEP - Prontuário Eletrônico do Paciente (Non-US) (Brazil Only) [R] L R	86.7	n=6	B-	A	B+	B+	A-	B-

Company/solution	Overall performance score (100-point scale)	Total evaluations

Dedalus xHIS (Non-US) (DXC Technology) * L culture D+ loyalty D- operations D- product F relationship D+ value F	59.4	n=5

InterSystems TrakCare EPR (Non-US) [R] (Chile Only) culture B loyalty A operations B- product B relationship B value B	84.7	n=11

SPDATA PEP - Prontuário Eletrônico do Paciente (Non-US) (Brazil Only) [R] L R culture B- loyalty A operations B+ product B+ relationship A- value B-	86.7	n=6

Acute Care EMR - Global

Past Acute Care EMR - Global Awards

Contact KLAS

Tell us about your organization

How can we help you?